Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-THK-5351 PET Imaging in Alzheimer's Disease
NCT02884492Phase 2Terminated
- Start
- Jul 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 18F-THK5351 in Alzheimer's disease (AD). Started Jul 2016; status: terminated.
02
Drugs
18F-THK5351
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02884492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02884492.